Live webcast on April 29, 11am PDT | 2pm EDT
Getting the green light to begin clinical development is a major milestone for any injectable molecule. It’s the time when an API becomes a human-ready drug product.
It’s also the point at which drug owners trade benchtop exploration for market readiness rigor: well-controlled processes, cGMP requirements, regulatory expectations, and more. Preparing for these new priorities is an essential part of entering a Phase I clinical trial.
In this webcast, clinical manufacturing experts who have supported over 150 companies and 300 compounds will share their best planning practices how to navigate this critical transition and successfully, unlocking a new development phase for your products.
Join us to find out how you can make the transition from pre-clinical to clinical development as efficient and smooth as possible.